ALNYLAM PHARMACEUTICALS, INC. Accounts Receivable 2017-2025 | ALNY
What is accounts receivable?
Accounts receivable represents money owed to the company by customers for goods or services already delivered but not yet paid for.
What is ALNYLAM PHARMACEUTICALS, INC.'s current accounts receivable?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual accounts receivable for 2025 was $777.6M, a 91.85% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. accounts receivable for the quarter ending December 31, 2025 was $777.6M.
What was ALNYLAM PHARMACEUTICALS, INC.'s accounts receivable in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual accounts receivable for 2024 was $405.3M, a 23.65% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s accounts receivable in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual accounts receivable for 2023 was $327.8M, a 37.75% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year accounts receivable CAGR?
ALNYLAM PHARMACEUTICALS, INC. accounts receivable grew at a compound annual growth rate (CAGR) of 49.99% from FY2020 to FY2025, going from $102.4M to $777.6M over 5 years.
Year-over-year comparison from 10-K annual reports